SEC Filing Analysis: RESMED INC (RMD)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chairman and CEO, Michael J. Farrell, acquired a net 6,254 shares of common stock following the vesting of performance-based restricted stock units (RSUs) originally granted in 2022.
• Market Impact: The transaction is a routine compensation event with a negligible impact on share dilution or market sentiment.

Company Information

Field	Value
Company	RESMED INC
Ticker Symbol	RMD
CIK	0000943819
Industry	Surgical & Medical Instruments & Apparatus
Market Cap	$35.68 Billion

Insider Information

Field	Value
Name	Farrell Michael J.
CIK	0001485164
Title/Position	Chairman and CEO
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-20
Transaction Code	A (Award), F (Tax Withholding)
Security Type	ResMed Common Stock
Shares Involved	13,551 Acquired (Award), 7,297 Disposed (Taxes)
Price Per Share	$0.00
Total Value	$0 (as reported)
Shares Owned After	468,313 (Total Direct & Indirect)
Ownership Type	Direct & Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	Not calculable from filing (reported as $0)
% of Market Cap	~0.0%
Shares Transacted (Gross)	13,551
% of Shares Outstanding	0.009%
Post-Transaction Ownership	468,313 shares (0.32% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: As a large-cap company with a $35.68B market capitalization, the vesting of shares is a routine part of executive compensation and is not material in size.
• Ownership Concentration: The CEO's total ownership of 0.32% remains a small fraction of the total shares outstanding, which is typical for a non-founder CEO of a large public company.
• Dilution Impact: The issuance of these shares represents a negligible dilution of ~0.009% to existing shareholders and was likely factored into diluted EPS calculations since the grant date in 2022.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a non-discretionary transaction related to a pre-existing compensation plan. It does not signal a new investment decision by the insider.

Volume & Sentiment

• Expected Volume Impact: Minimal. The shares were vested, not purchased on the open market.
• Sentiment Indicator: Neutral. The transaction is a routine part of an executive compensation package.

Additional Context

Transaction Notes

• Special Circumstances: The filing details two related transactions: an award (Code A) for 13,551 shares from vesting performance-based RSUs, and a disposition (Code F) of 7,297 shares to the issuer to cover tax liabilities. The net result is an increase of 6,254 shares in the insider's holdings.